Back to top
more

Medtronic (MDT)

(Delayed Data from NYSE)

$79.34 USD

79.34
22,656,004

+1.20 (1.54%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $79.66 +0.32 (0.40%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 34% (164 out of 247)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Indrajit Bandyopadhyay headshot

ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now?

by Indrajit Bandyopadhyay

ISRG trades just 4% below its record high after a 32% surge over the past three months, driven by strong procedure growth, rising utilization, and early traction for the da Vinci 5 system.

Zacks Equity Research

The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson

by Zacks Equity Research

Eli Lilly highlights how AI is transforming healthcare, from drug discovery to diagnostics, turning defensive medical stocks into growth plays for 2026.

Nalak Das headshot

Watch 5 AI-Powered Medical Stocks for a Strong Portfolio in 2026

by Nalak Das

LLY, MDT, ISRG, REGN and JNJ are five defensive medical stocks using AI to drive growth, diagnostics and innovation into 2026.

Moumi Mondal headshot

How Is Boston Scientific's Cardiovascular Growth Path Shaping Up?

by Moumi Mondal

BSX's $50B cardiovascular business aims to outpace market growth across EP, WATCHMAN, ICTx and more.

Zacks Equity Research

The Zacks Analyst Blog Highlights Cardinal Health, Medtronic, Intuitive Surgical and Edwards Lifesciences

by Zacks Equity Research

Cardinal Health leads Zacks' list of large-cap MedTech stocks as AI adoption, robotics and rising procedure volumes set up continued gains in 2026.

Moumi Mondal headshot

Should You Hold On To BSX Stock Despite Its Premium Valuation?

by Moumi Mondal

Boston Scientific trades at a premium, but strong momentum in WATCHMAN, EP and MedSurg growth keeps long-term shareholders in the game despite valuation risks.

Zacks Equity Research

MDT vs. ESLOY: Which Stock Is the Better Value Option?

by Zacks Equity Research

MDT vs. ESLOY: Which Stock Is the Better Value Option?

Harshit Gupta headshot

4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026

by Harshit Gupta

Four large-cap MedTech leaders, MDT, ISRG, CAH, EW, appear well-positioned to extend their winning streaks in 2026 on resilient procedure demand and innovation.

Mark Vickery headshot

Top Research Reports for NVIDIA, Netflix & Merck

by Mark Vickery

New research highlights NVIDIA's AI-driven growth, Netflix's ad-tier momentum and Merck's pipeline progress, while microcaps also make the cut.

Zacks Equity Research

Why Is Medtronic (MDT) Down 2% Since Last Earnings Report?

by Zacks Equity Research

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.